Novartis

Novartis signs $1.1B deal for muscular dystrophy biotech

Novartis had one eye on the struggles its peers have encountered in the muscular dystrophy space when bought Kate Therapeutics, the pharma’s CEO said.

James Waldron Nov 21, 2024 8:19am

Novartis 'took data to heart' before slimming pipeline by 40%

Nov 21, 2024 5:07am

Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together

Novartis taps Vyriad’s viral vectors for in vivo T cell editing

Nov 20, 2024 12:00pm

Novartis taps Ratio for $745M radiopharmaceutical pact

Nov 18, 2024 8:00am

Novartis pays Schrödinger $150M to form drug discovery pact

Nov 12, 2024 8:55am

VC firm, Chinese biotech launch autoimmune-focused Oblenio Bio

Nov 7, 2024 11:35am